Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

European Commission Drops Boehringer Case And Lauds Itself For Receding Patent Abuse

This article was originally published in The Pink Sheet Daily

Executive Summary

Boehringer Ingelheim's settlement with Almirall in an alleged patent abuse case shows that the EU pharmaceutical inquiry had a desired effect, the Commission maintains.

You may also be interested in...



Brand-Generic "Pay-For-Delay" Settlements Jump 63% In FY 2010

As a proportion of total settlements reported to FTC, however, the ones involving compensation to the generic firm remained the same.

AstraZeneca's ECJ Setback May Impact European IP Protection Strategies

The European Court of Justice sides with the European Commission: manipulating the patent and regulatory systems to block competitors gets AZ a slap on the wrist and serves as a warning to others.

Quelle Surprise! EU Investigators Raid Pharma Firms

Government officials investigate possible obstacles to competition in the drug industry, expect a preliminary report this fall.

Topics

UsernamePublicRestriction

Register

ID005817

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel